Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer. | Int J Environ Res Public Health | 2022 | 35886427 | PubTator, text mining | PubMed |
| Current State of Cell Therapies for Breast Cancer. | Cancer J | 2022 | 35880940 | PubTator, text mining | PubMed |
| Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy. | Mater Today Bio | 2022 | 35880099 | PubTator, text mining | PubMed |
| The emergence of nanoporous materials in lung cancer therapy. | Sci Technol Adv Mater | 2022 | 35875329 | PubTator, text mining | PubMed |
| Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells. | Front Immunol | 2022 | 35874714 | PubTator, text mining | PubMed |
| Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade. | Front Immunol | 2022 | 35874702 | PubTator, text mining | PubMed |
| Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen. | Aging Dis | 2022 | 35855340 | PubTator, text mining | PubMed |
| Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy. | J Immunother Cancer | 2022 | 35851311 | PubTator, text mining | PubMed |
| Molecular mimicry between tumor associated antigens and microbiota-derived epitopes. | J Transl Med | 2022 | 35836198 | PubTator, text mining | PubMed |
| Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer. | Front Immunol | 2022 | 35833132 | PubTator, text mining | PubMed |
| Tumor Microenvironment Characterization in Breast Cancer and an Immune Cell Infiltration Score Development, Validation, and Application. | Front Oncol | 2022 | 35832543 | PubTator, text mining | PubMed |
| Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story. | Cancers (Basel) | 2022 | 35805007 | PubTator, text mining | PubMed |
| Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. | Oncoimmunology | 2022 | 35800158 | PubTator, text mining | PubMed |
| Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers. | J Immunother Cancer | 2022 | 35798537 | PubTator, text mining | PubMed |
| A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection. | Sci Rep | 2022 | 35794133 | PubTator, text mining | PubMed |
| Analysis of potential biomarkers of response to IL-12 therapy. | J Leukoc Biol | 2022 | 35790025 | PubTator, text mining | PubMed |
| Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability. | Front Oncol | 2022 | 35774131 | PubTator, text mining | PubMed |
| NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome. | J Immunother Cancer | 2022 | 35768164 | PubTator, text mining | PubMed |
| Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden. | Cancer | 2022 | 35767280 | PubTator, text mining | PubMed |
Pathological stage-associated non-coding RNA long intergenic non-protein coding RNA 1234 (LINC01234) participation in cell cycle regulation in adrenocortical carcinoma through bromodomain-containing protein 4 (BRD4) expression mediation via sponging microRNA (miR)-140-3p. | Bioengineered | 2022 | 35765893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=25